Top Stories
Cathie Wood’s ARK shifts focus, sells Adyen, buys Teradyne stock Source link
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
US stocks gained steam on Thursday afternoon as investors digested megacap…
US stocks gained steam on Thursday afternoon as investors digested megacap…
October 14, 2024: SpaceX’s Falcon Heavy is seen from the roof…
US stocks struggled to make headway on Thursday as investors digested…
Investments
When deciding whether to buy, sell, or hold a stock, investors often…
Economy Insights
National News
(Changes reference to ‘discrimination’ from ‘bias’ in paragraphs 4,7,9,11,12,14,18) By Daniel Wiessner (Reuters) -U.S. companies that scale back workplace diversity efforts to avoid scrutiny from the Trump…
By Valentina Za, Gianluca Semeraro and Mathieu Rosemain MILAN (Reuters) – Monte dei Paschi (MPS) CEO Luigi Lovaglio has pulled several all-nighters since arriving in Siena in…
MILAN (Reuters) – Italian billionaire Francesco Gaetano Caltagirone has emerged as a leading player in the reshaping of Italy’s financial sector that is currently under way. BATTLES…
In a notable performance, Texas Community Bancshares, Inc. (TCBS) stock reached a 52-week high, trading at $15.71. With a market capitalization of $45.18 million, the small-cap regional…
NEW YORK – January 24, 2025 (NEWMEDIAWIRE) – Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against FTAI Aviation Ltd. (FTAI…
By Stephanie van den Berg and Anthony Deutsch THE HAGUE – The International Criminal Court has taken measures to shield staff from possible U.S. sanctions, paying salaries…